At a glance
- Originator Pfizer
- Class Antiasthmatics
- Mechanism of Action Leukotriene D4 receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Asthma
Most Recent Events
- 23 Jun 2000 Pfizer has merged with Warner-Lambert
- 21 Mar 2000 Profile reviewed but no significant changes made
- 14 Sep 1998 New profile